ANIVANCE AI

Organ Chips; Biotechnology Instruments; Microfluidic Systems; Cell Culture Devices; Scientific laboratory research instruments for DNA analysis; Biological Simulation Devices

Medical Organ Chips; Diagnostic Microfluidic Devices; In Vitro Diagnostic Devices; Cell Therapy Devices; Medical Testing Chips; Medical Biological Simulation Devices; Medical instruments, namely, biosensors for detecting infectious diseases

Research and development services in the field of biotechnology; Organ Chip Development and Design; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals; Technical Consultation and Support; Laboratory services for the production of pharmaceuticals in the nature of testing of in vitro pharmaceuticals in the field of cellular biology; Laboratory services for the production of pharmaceuticals in the nature of providing simulations of cells in the field of cellular biology; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of human tissue for cellular biology purposes; Research and development in the field of cellular biology; Biological Simulation System Development; Microfluidic Technology Development

Medical diagnostic services; Personalized Medical Services; Organ Chip-Based Diagnostic Services; Regenerative Medicine Research Services; Health Assessment and Management; Cell Therapy Evaluation Services